Professional Documents
Culture Documents
OF BEHAVIOUR IN RATS
The Open Field Test situation is reported to produce autonomic nervous system re
activity determined emotional freezing and defecation (1, 2), cortical excitation determined
rearing activity (3), and corpus striatum activity determined stereotyped ambulation (4,
5). Thus autonomic depressant drugs reduce emotional freezing (6), cortical excitant
drugs augment rearing (7, 8), and hallucinatory drugs facilitate stereotyped ambulation
(4).<BR>
It has been reported (3) that selective stimulation of stereotyped ambulation with
suppression of interrupting responses of rearing or preening is a typical action of increas
ing doses of LSD or iproniazid. This typical drug effect can be differentiated from that
of amphetamine which in increasing doses facilitates rearing and simultaneously blocks
preening as well as stereotyped ambulation; a third type of drug effect being that of imi
pramine which in increasing doses inhibits preening but failing to modify ambulation or
rearing in rats. In the present study, attempts have been made to extend this approach
to other stimulant drugs, i.e. methyl phenidate, pentylene tetrazol, mescaline, caffeine and
pargyline for arriving at some definite conclusions regarding the multidimensional Open
Field performance and the pharmacological manipulation there of.
Subjects: The subjects of the present investigation were albino rats of 100 to 450g
body weight. The experimental design was composed of 30 groups (6 treatments 5 doses
of each treatment); each group was composed of five male rats. Thus, in all 150 animals
were subjected to the experiment.
Apparatus: The apparatus for the Open Field Test was similar to that used by
Dandiya et al. (4). Briefly, it consisted of an open arena of 323/4inches diameter enclosed
by a wall. The floor was marked out in three concentric circles divided into segments by
lines radiating from the floor centre. The markings provided 25 floor units of approxi
mately equal size. In the Open Field Test, two types of stimuli were presented to the sub
ject, white noise of 78 dB and bright light of 165 footcandles. Hand-operated counters
were used to record the frequency of ambulation, rearing, and preening responses. The
ambulation response was defined as the "walking around" score derived from the number
of radial segments of the arena which were crossed by the subject during the test. Rear
ing response was defined by the number of times the subject stood on its hind limbs.
Copyright 1971. Production and Hosting by Elseiver B.V. On behalf of Japanese Pharmacological Society.
This is an open access article under the CC BY-NC-ND License (http://creativecommons.org/licenses/by-nc-nd/ ).
Preening score was determined by the number of times the animal scratched its face with
its fore-arms. Defecation score was the number of faecal boluses deposited by the sub
ject on the floor during the test.
Procedure: Double distilled water was used as carrier for all the drugs administered.
According to the body weight of the animal, the required volume of the drug solution or
the distilled water (placebo) was injected intraperitoneally. The concentration of the
drug solutions was such that an animal weighing 250 g may not get more than I ml of the
solution. The doses and the absorption period (latency) of the drugs are listed in Table
1. There were uniform differences between the logarithms of the doses. As soon as
the latency period of the drug elapsed, the treated subiect was carried to the apparatus.
Each subject was tested only for two minutes and scores on ambulation, rearing, preen
ing and defecation were recorded.
TABLE
1. The drugs, dose and the latency period. Each drug group was
composedof 25 rats divided into 5 subgroups. Each subgroup was
given a differentdose (I to V) of the drug intraperitoneallybefore
subjectingthemto the Open Field Test. Figures under columns I
to V are of doses in mg/kg. Latency is the time in hours allowed
betweendrug administrationand subjectingto the Open Field Test.
Placebo was double distilledwater.
RESULTS
A simple analysis of variance was performed on each of the four measures separately.
The analysis of ambulation score showed that the "treatment" effect (F-ratio=21.98:
P<0.01) and its interaction with the "dose" effect (F-ratio=7.52; P<0.01) were produc
ing significant group differences. A breakdown of the "treatment effect" by student's
t-test against the residual variance (Table 2) showed that, except pargyline, each drug
facilitated ambulation as compared with the placebo control; caffeine producing a higher
TABLE 4. The t-test comparisons of the treatment group means on preening scores.
N-= 25.
TABLE5. The t-test comparisons of the treatment group means on defecation scores.
N= 25.
FIG. 1. Mean ambulation (locomotion) scores FIG. 2. Mean rearing (standing up on hind
of rats subjected to Open Field Test after limbs) scores of rats subjected to Open
administration of five increasing doses (in Field Test after administration of five
logarithms) of methylphenidate (MEP), increasing doses (in logarithms) of mehyl
pargyline (PARG), pentylenetetrazol phenidate (MEP), pargyline (PARG),
(PEN), mescaline (MES) and caffeine pentylenetetrazol (PEN), mescaline(MES)
(CAF). and caffeine (CAF).
DISCUSSION
Taken together, the results of the present experiment have demonstrated that Open
Field behaviour of rats can be modified by the drugs employed in the study. However,
in the Open Field Test may be a behavioural response of the sympathetic nervous system
over-reactivity (1) and pipradrol (9) or amphetamine (3) fail to augment this response.
Thus, it may be argued that pentylenetetrazol facilitates the defecation responses possibly
due to its overall excitatory effect on central nervous system including those nervous loci
of posterior hypothalamus which control the reactivity of sympathetic nervous system
(10).
Increasing doses of mescaline produce a linear facilitation of ambulation in a fixed
pattern in the outer-most circle of the Open Field arena with a simultaneous inhibition
of interrupting responses of rearing and preening-a behavioural function similar to that
of LSD (4) or of iproniazid (3) in producing this type of stereotyped ambulation (7, 5).
Thus, mescaline produces stereotyped ambulation in contrast to caffeine, methylphenidate
or pentylenetetrazol which, like amphetamine (3), reduce this behavioural pattern; in
creasing doses of these drugs, however, showing a non-linear facilitation of exploratory
ambulation in the Open Field Test. It is interesting to note that a typical pattern of fa
cilitation of rearing with a simultaneous inhibition of preening responses is a function of
these drugs in the following order: methylphenidate, caffeine, and pentylenetetrazol. On
the other hand, pargyline, which fails to affect rearing or ambulation, inhibits preening
behaviour to a larger extent. Thus, as far as the inhibition of preening responses is con
cerned, both central stimulant and anti-depressant drugs have this property; however,
differing from each other in their action on rearing performance. It has been reported
that rearing and preening responses may be behavioural correlates of cortical excitation
and inhibition respectively (3, 7). It may be argued that the central stimulant drugs may
reduce preening by increasing cortical excitation and thereby shifting the "excitation-in
hibition" balance in favour of "excitation" for increasing rearing at the cost of preening.
The anti-depressant drug (pargyline), on the other hand, inhibits preening by directly re
ducing cortical "inhibition"; failing to affect cortical excitation determined rearing.
SUMMARY
In order to find a suitable explanation for the differential behavioural effects of the
Acknowledgement: Authors are thankful to the Indian Council of Medical Research for
providing financial assistance for this study.
REFERENCES
1) BROADHURST,
P.L.: Br. J. Psychol. 48, 1 (1957)
2) HOLLAND, H.C. AND GUPTA, B.D.: Ann. Behav. 14, 574 (1966)
3) GUPTA, B.D., DANDIYA,P.C., GUPTA, M.L. AND GABA, A.K.: Europ. J. Pharmac. 13, 341
(1971)
4) DANDIYA,P.C., GUPTA, B.D., GUPTA, M.L. AND PATNI, S.K.: Psychopharmac. 15, 333
(1969)
5) RANDRUP, A. AND MUNKVAD,I.: Pharmakopsychiatrie Neuro-Psychopharmnakologie 1, 18
(1968)
6) RUSHTON,R. AND STEINBERG,H.: Br. J. Pharmac. Chemother. 21, 295 (1963)
7) LAT, J.: Proc. 2nd Int. Pharm. Meeting, 22-23 Aug., 1963. Czechoslovak Medical Press,
Praha, 47-66 (1965)
8) GUPTA, B.D. AND GREGORY,K.: Psychopharmac. 11, 365 (1967)
9) BROADHURST,
P.L., SINHA, S.D. AND SINGH, S.D.: J. Genet. Psychol. 95, 217 (1959)
10) EYSENCK,H.J.: Behav. Res. Ther. 1, 197 (1963)